Vaccination With a Single Consensus Envelope Protein Ectodomain Sequence Administered in a Heterologous Regimen Induces Tetravalent Immune Responses and Protection Against Dengue Viruses in Mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccination With a Single Consensus Envelope Protein Ectodomain Sequence Administered in a Heterologous Regimen Induces Tetravalent Immune Responses and Protection Against Dengue Viruses in Mice
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-05-10
DOI
10.3389/fmicb.2019.01113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic review of health economic evaluation studies of dengue vaccines
- (2019) Patrícia Coelho de Soárez et al. VACCINE
- Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial
- (2018) Janine R. Danko et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI® induces enhanced serological, cellular and protective immune responses
- (2018) Weiping Cao et al. DRUG DELIVERY
- Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2–17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study
- (2018) Xavier Sáez-Llorens et al. LANCET INFECTIOUS DISEASES
- Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
- (2018) Saranya Sridhar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice
- (2018) Ran Wang et al. VACCINE
- Heterologous prime–boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus
- (2018) Seo-Yeon Jung et al. VACCINE
- Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine
- (2018) Annelies Wilder-Smith et al. LANCET INFECTIOUS DISEASES
- Combination of cell penetrating peptides and heterologous DNA prime/protein boost strategy enhances immune responses against HIV-1 Nef antigen in BALB/c mouse model
- (2017) Somayeh Kadkhodayan et al. IMMUNOLOGY LETTERS
- Newer Vaccines against Mosquito-borne Diseases
- (2017) Anju Aggarwal et al. INDIAN JOURNAL OF PEDIATRICS
- Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study
- (2017) Xavier Sáez-Llorens et al. LANCET INFECTIOUS DISEASES
- Combination of the immunization with the sequence close to the consensus sequence and two DNA prime plus one VLP boost generate H5 hemagglutinin specific broad neutralizing antibodies
- (2017) Guiqin Wang et al. PLoS One
- Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence
- (2017) Jin Sun et al. VACCINE
- DNA vaccination protects mice against Zika virus-induced damage to the testes
- (2017) Bryan D. Griffin et al. Nature Communications
- In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination
- (2017) Stephen S. Whitehead et al. PLoS Neglected Tropical Diseases
- Effective Protection Induced by a Monovalent DNA Vaccine against Dengue Virus (DV) Serotype 1 and a Bivalent DNA Vaccine against DV1 and DV2 in Mice
- (2017) Xiaoyan Zheng et al. Frontiers in Cellular and Infection Microbiology
- DNA Vaccine Protects Monkeys Against Zika Virus Infection
- (2016) Tracy Hampton JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naïve and dengue exposed individuals
- (2016) Sandra Henein et al. JOURNAL OF INFECTIOUS DISEASES
- Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses
- (2016) Donald M. Carter et al. JOURNAL OF VIROLOGY
- Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere
- (2016) Helen M. Lazear et al. JOURNAL OF VIROLOGY
- The global burden of dengue: an analysis from the Global Burden of Disease Study 2013
- (2016) Jeffrey D Stanaway et al. LANCET INFECTIOUS DISEASES
- Rapid development of a DNA vaccine for Zika virus
- (2016) K. A. Dowd et al. SCIENCE
- Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment
- (2016) Neil M. Ferguson et al. SCIENCE
- The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model
- (2016) Beth D. Kirkpatrick et al. Science Translational Medicine
- Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study
- (2015) Jenna Aviles et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial
- (2015) Sarah L. George et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study
- (2015) Chukiat Sirivichayakul et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study
- (2015) Richard Rupp et al. VACCINE
- Short Conserved Sequences of HIV-1 Are Highly Immunogenic and Shift Immunodominance
- (2014) Otto O. Yang et al. JOURNAL OF VIROLOGY
- Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge
- (2014) Marina De Filette et al. PLoS One
- Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine
- (2014) Jian Yan et al. VACCINE
- Vaccination of Captive Nēnē (Branta sandvicensis) against West Nile Virus Using a Protein-based Vaccine (WN-80E)
- (2013) Susan I. Jarvi et al. JOURNAL OF WILDLIFE DISEASES
- Physicochemical property consensus sequences for functional analysis, design of multivalent antigens and targeted antivirals
- (2012) Catherine H Schein et al. BMC BIOINFORMATICS
- The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
- (2010) Martina Beltramello et al. Cell Host & Microbe
- Genetic heterologous prime–boost vaccination strategies for improved systemic and mucosal immunity
- (2009) Charani Ranasinghe et al. Expert Review of Vaccines
- A Protective Role for Dengue Virus-Specific CD8+ T Cells
- (2009) L. E. Yauch et al. JOURNAL OF IMMUNOLOGY
- Vaccination of calves using the BRSV nucleocapsid protein in a DNA prime–protein boost strategy stimulates cell-mediated immunity and protects the lungs against BRSV replication and pathology
- (2008) Letellier Carine et al. VACCINE
- DNA vaccines and their applications in veterinary practice: current perspectives
- (2008) K. Dhama et al. VETERINARY RESEARCH COMMUNICATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now